![](https://webarchive.library.unt.edu/eot2008/20090509220150im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090509220150im_/http://www.cancer.gov/images/spacer.gif)
recombinant platelet factor 4 A recombinant form of the endogenous chemokine platelet factor 4 with potential antiangiogenesis and antineoplastic activities. As a heparin-binding tetramer, recombinant platelet factor 4 inhibits growth factor-stimulated endothelial cell proliferation, migration, and angiogenesis; it has been shown that this agent inhibits fibroblast growth factor 2 (FGF2) angiogenic activity downstream from the FGF2 receptor. Its activity is antagonized by heparin. Recombinant platelet factor 4 may also directly inhibit the proliferation of some tumor cell types. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
![](https://webarchive.library.unt.edu/eot2008/20090509220150im_/http://www.cancer.gov/images/spacer.gif)
Synonyms: | ![](https://webarchive.library.unt.edu/eot2008/20090509220150im_/http://www.cancer.gov/images/spacer.gif) | CXC-chemokine PF-4 CXCL4 platelet factor 4 recombinant human platelet factor 4 | | ![](https://webarchive.library.unt.edu/eot2008/20090509220150im_/http://www.cancer.gov/images/spacer.gif) | Acronyms: | ![](https://webarchive.library.unt.edu/eot2008/20090509220150im_/http://www.cancer.gov/images/spacer.gif) | rhPF4 rPF4 rPF4 | | ![](https://webarchive.library.unt.edu/eot2008/20090509220150im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20090509220150im_/http://www.cancer.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20090509220150im_/http://www.cancer.gov/images/gray_spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20090509220150im_/http://www.cancer.gov/images/spacer.gif)
|
![](https://webarchive.library.unt.edu/eot2008/20090509220150im_/http://www.cancer.gov/images/spacer.gif) |